Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06935214

The Repeatability of the Effect of Caffeine Supplementation on Submaximal Physiological Responses and Cycling Time Trial Performance

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
St. Mary's University, Twickenham · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Recently, Grgic (2018) discussed the concept of responders and non-responders to caffeine supplementation highlighting the importance of the repeatability of results. However, the number of studies that have investigated this idea by repeating the same time-trial performance test multiple times with the same caffeine dose is sparse (Astorino et al., 2012; Del Coso et al., 2019). Furthermore, studies have shown that differences in the CYP1A2 genotype may account for some of the variation in time-trial performance (Guest et al., 2018). Thus, the current study aims to identify whether the effects of moderate caffeine supplementation (5 mg/kg) on time-trial performance are repeatable to aid the identification of responders and non-responders. Additionally, the study aims to determine if the CYP1A2 genotype may explain any of the variability in time-trial performance in trained male cyclists.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCaffeine5 mg/kg of caffeine in pill form
DIETARY_SUPPLEMENTPlacebo5 mg/kg dose of maltodextrin in pill form
DIETARY_SUPPLEMENTCaffeine5 mg/kg dose of caffeine in pill form

Timeline

Start date
2025-05-01
Primary completion
2025-08-23
Completion
2025-12-31
First posted
2025-04-20
Last updated
2025-04-20

Source: ClinicalTrials.gov record NCT06935214. Inclusion in this directory is not an endorsement.